Cargando…

Comparative analysis of the neutralizing activity against SARS-CoV-2 Wuhan-Hu-1 strain and variants of concern: Performance evaluation of a pseudovirus-based neutralization assay

OBJECTIVES: Emergence of new variants of SARS-CoV-2 might affect vaccine efficacy. Therefore, assessing the capacity of sera to neutralize variants of concern (VOCs) in BSL-2 conditions will help evaluating the immune status of population following vaccination or infection. METHODS: Pseudotyped viru...

Descripción completa

Detalles Bibliográficos
Autores principales:	D’Apice, Luciana, Trovato, Maria, Gramigna, Giulia, Colavita, Francesca, Francalancia, Massimo, Matusali, Giulia, Meschi, Silvia, Lapa, Daniele, Bettini, Aurora, Mizzoni, Klizia, Aurisicchio, Luigi, Di Caro, Antonino, Castilletti, Concetta, De Berardinis, Piergiuseppe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9549111/ https://www.ncbi.nlm.nih.gov/pubmed/36225911 http://dx.doi.org/10.3389/fimmu.2022.981693

Ejemplares similares

Differential Dynamics of SARS-CoV-2 Binding and Functional Antibodies upon BNT162b2 Vaccine: A 6-Month Follow-Up
por: Matusali, Giulia, et al.
Publicado: (2022)

Booster Dose of SARS-CoV-2 mRNA Vaccine in Kidney Transplanted Patients Induces Wuhan-Hu-1 Specific Neutralizing Antibodies and T Cell Activation but Lower Response against Omicron Variant
por: Del Mastro, Andrea, et al.
Publicado: (2023)

Retention of Neutralizing Response against SARS-CoV-2 Omicron Variant in Sputnik V-Vaccinated Individuals
por: Lapa, Daniele, et al.
Publicado: (2022)

SARS-CoV-2 Serum Neutralization Assay: A Traditional Tool for a Brand-New Virus
por: Matusali, Giulia, et al.
Publicado: (2021)

HIV Vaccination: A Roadmap among Advancements and Concerns
por: Trovato, Maria, et al.
Publicado: (2018)

Viral Emerging Diseases: Challenges in Developing Vaccination Strategies
por: Trovato, Maria, et al.
Publicado: (2020)

Exploiting viral sensing mediated by Toll-like receptors to design innovative vaccines
por: Sartorius, Rossella, et al.
Publicado: (2021)

SARS-CoV-2 Breakthrough Infections According to the Immune Response Elicited after mRNA Third Dose Vaccination in COVID-19-Naïve Hospital Personnel
por: Santoro, Annapaola, et al.
Publicado: (2023)

Co-Delivery of the Human NY-ESO-1 Tumor-Associated Antigen and Alpha-GalactosylCeramide by Filamentous Bacteriophages Strongly Enhances the Expansion of Tumor-Specific CD8+ T Cells
por: Manco, Roberta, et al.
Publicado: (2023)

Monkeypox virus isolation from a semen sample collected in the early phase of infection in a patient with prolonged seminal viral shedding
por: Lapa, Daniele, et al.
Publicado: (2022)

Evaluation of Cross-Immunity to the Mpox Virus Due to Historic Smallpox Vaccination
por: Matusali, Giulia, et al.
Publicado: (2023)

Stimulation of Innate and Adaptive Immunity by Using Filamentous Bacteriophage fd Targeted to DEC-205
por: D'Apice, Luciana, et al.
Publicado: (2015)

Performance evaluation of Abbott ARCHITECT SARS-CoV-2 IgG immunoassay in comparison with indirect immunofluorescence and virus microneutralization test
por: Meschi, Silvia, et al.
Publicado: (2020)

Arming Filamentous Bacteriophage, a Nature-Made Nanoparticle, for New Vaccine and Immunotherapeutic Strategies
por: Sartorius, Rossella, et al.
Publicado: (2019)

Biomimetic nanoplasmonic sensor for rapid evaluation of neutralizing SARS-CoV-2 monoclonal antibodies as antiviral therapy
por: Batool, Razia, et al.
Publicado: (2023)

High-throughput analysis of anti-poliovirus neutralization antibody titre in human serum by the pseudovirus neutralization test
por: Arita, Minetaro, et al.
Publicado: (2022)

A simple and safe antibody neutralization assay based on polio pseudoviruses
por: Jiang, Zheng, et al.
Publicado: (2018)

A Simplified SARS-CoV-2 Pseudovirus Neutralization Assay
por: Donofrio, Gaetano, et al.
Publicado: (2021)

Application of pseudovirus system in the development of vaccine, antiviral-drugs, and neutralizing antibodies
por: Xiang, Qi, et al.
Publicado: (2022)

Co-Immunization with Multimeric Scaffolds and DNA Rapidly Induces Potent Autologous HIV-1 Neutralizing Antibodies and CD8(+) T Cells
por: Jaworski, Juan Pablo, et al.
Publicado: (2012)

Synergy in monoclonal antibody neutralization of HIV-1 pseudoviruses and infectious molecular clones
por: Miglietta, Riccardo, et al.
Publicado: (2014)

Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2
por: Nie, Jianhui, et al.
Publicado: (2020)

Comparison of VSV Pseudovirus and Focus Reduction Neutralization Assays for Measurement of Anti-Andes orthohantavirus Neutralizing Antibodies in Patient Samples
por: Vial, Cecilia, et al.
Publicado: (2020)

Development of a Coxsackievirus A16 neutralization assay based on pseudoviruses for measurement of neutralizing antibody titer in human serum
por: Jin, Jun, et al.
Publicado: (2013)

Distinct Antigen Delivery Systems Induce Dendritic Cells’ Divergent Transcriptional Response: New Insights from a Comparative and Reproducible Computational Analysis
por: Costa, Valerio, et al.
Publicado: (2017)

Evaluation of a Pseudovirus Neutralization Assay for SARS-CoV-2 and Correlation with Live Virus-Based Micro Neutralization Assay
por: Tolah, Ahmed Majdi K., et al.
Publicado: (2021)

Packaging of Rift Valley fever virus pseudoviruses and establishment of a neutralization assay method
por: Li, Yuetao, et al.
Publicado: (2018)

A high-throughput SARS-CoV-2 pseudovirus multiplex neutralization assay
por: Sievers, Benjamin Louis, et al.
Publicado: (2022)

Evidences for lipid involvement in SARS-CoV-2 cytopathogenesis
por: Nardacci, Roberta, et al.
Publicado: (2021)

Vectorized Delivery of Alpha-GalactosylCeramide and Tumor Antigen on Filamentous Bacteriophage fd Induces Protective Immunity by Enhancing Tumor-Specific T Cell Response
por: Sartorius, Rossella, et al.
Publicado: (2018)

Development of a pseudovirus based assay for measuring neutralizing antibodies against coxsackievirus B5
por: Chen, Pan, et al.
Publicado: (2017)

Sensitivity of Human Papillomavirus (HPV) Lineage and Sublineage Variant Pseudoviruses to Neutralization by Nonavalent Vaccine Antibodies
por: Godi, Anna, et al.
Publicado: (2019)

Neutralization of SARS-CoV-2 pseudovirus using ACE2-engineered extracellular vesicles
por: Wu, Canhao, et al.
Publicado: (2022)

Establishment of a neutralization assay for Nipah virus using a high-titer pseudovirus system
por: Luo, Xiaoyi, et al.
Publicado: (2023)

A Pseudovirus-Based Entry Assay to Evaluate Neutralizing Activity against Respiratory Syncytial Virus
por: Hu, Longbo, et al.
Publicado: (2023)

Triggering DTH and CTL Activity by fd Filamentous Bacteriophages: Role of CD4+ T Cells in Memory Responses
por: Del Pozzo, Giovanna, et al.
Publicado: (2010)

Tropism of the Chikungunya Virus
por: Matusali, Giulia, et al.
Publicado: (2019)

SARS-CoV-2 Omicron Variant Neutralization after Third Dose Vaccination in PLWH
por: Vergori, Alessandra, et al.
Publicado: (2022)

Analysis of Cross-Reactive Neutralizing Antibodies in Human HFMD Serum with an EV71 Pseudovirus-Based Assay
por: Zhang, Huafei, et al.
Publicado: (2014)

Evaluation of antigenic differences between wild and Sabin vaccine strains of poliovirus using the pseudovirus neutralization test
por: Arita, Minetaro, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_iu255jk6pduorp63p09ohse2vt